Crescent Biopharma Inc
F:C68
During the last 3 months Crescent Biopharma Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 10% over this period (open performance analysis).
The last transaction was made on
Dec 4, 2025
by
Fairmount Healthcare Fund Ii L.p.
, who
bought
18.2m EUR
worth of 
C68 shares.
During the last 3 months Crescent Biopharma Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 10% over this period (open performance analysis).
The last transaction was made on
Dec 4, 2025
by
Fairmount Healthcare Fund Ii L.p.
, who
bought
18.2m EUR
worth of C68 shares.
Crescent Biopharma Inc
Glance View
Crescent Biopharma, Inc. operates as a biopharmaceutical company that develops and designs small molecule therapeutics to treat cancers. The company is headquartered in Waltham, Massachusetts and currently employs 4 full-time employees. The company went IPO on 2014-01-10. The firm is focused on advancing the next wave of therapies for cancer patients. The Company’s pipeline includes its lead program, a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates. The Company’s lead program is CR-001, a tetravalent PD-1 x VEGF bispecific antibody in development for the treatment of solid tumors, and it is also advancing CR-002 and CR-003, antibody drug conjugates (ADCs) with topoisomerase inhibitor payloads. CR-002 and CR-003 are ADCs designed to deliver clinically active cytotoxic drugs known as topoisomerase inhibitors to tumor cells. Each of these programs has the potential to deliver therapeutics with clinical efficacy both as a monotherapy and in combination with CR-001 with significant potential across solid tumor indications.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
